Soleno Therapeutics Statistics
Total Valuation
SLNO has a market cap or net worth of $2.83 billion. The enterprise value is $2.33 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLNO has 53.71 million shares outstanding. The number of shares has increased by 28.16% in one year.
| Current Share Class | 53.71M |
| Shares Outstanding | 53.71M |
| Shares Change (YoY) | +28.16% |
| Shares Change (QoQ) | +8.79% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 122.90% |
| Float | 52.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.36 |
| PS Ratio | 25.90 |
| Forward PS | 6.82 |
| PB Ratio | 5.72 |
| P/TBV Ratio | 5.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.08, with a Debt / Equity ratio of 0.11.
| Current Ratio | 16.08 |
| Quick Ratio | 15.77 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.34 |
Financial Efficiency
Return on equity (ROE) is -20.66% and return on invested capital (ROIC) is -12.92%.
| Return on Equity (ROE) | -20.66% |
| Return on Assets (ROA) | -11.75% |
| Return on Invested Capital (ROIC) | -12.92% |
| Return on Capital Employed (ROCE) | -14.87% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | -$852,717 |
| Employee Count | 92 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.03% in the last 52 weeks. The beta is -3.15, so SLNO's price volatility has been lower than the market average.
| Beta (5Y) | -3.15 |
| 52-Week Price Change | +3.03% |
| 50-Day Moving Average | 57.77 |
| 200-Day Moving Average | 66.99 |
| Relative Strength Index (RSI) | 51.16 |
| Average Volume (20 Days) | 1,984,439 |
Short Selling Information
The latest short interest is 9.73 million, so 18.12% of the outstanding shares have been sold short.
| Short Interest | 9.73M |
| Short Previous Month | 8.48M |
| Short % of Shares Out | 18.12% |
| Short % of Float | 18.37% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, SLNO had revenue of $98.68 million and -$78.45 million in losses. Loss per share was -$1.62.
| Revenue | 98.68M |
| Gross Profit | 96.84M |
| Operating Income | -84.27M |
| Pretax Income | -78.45M |
| Net Income | -78.45M |
| EBITDA | -82.26M |
| EBIT | -84.27M |
| Loss Per Share | -$1.62 |
Full Income StatementBalance Sheet
The company has $498.93 million in cash and $52.66 million in debt, giving a net cash position of $503.42 million or $9.37 per share.
| Cash & Cash Equivalents | 498.93M |
| Total Debt | 52.66M |
| Net Cash | 503.42M |
| Net Cash Per Share | $9.37 |
| Equity (Book Value) | 494.81M |
| Book Value Per Share | 9.21 |
| Working Capital | 501.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.90 million and capital expenditures -$23,000, giving a free cash flow of -$25.92 million.
| Operating Cash Flow | -25.90M |
| Capital Expenditures | -23,000 |
| Free Cash Flow | -25.92M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
Gross margin is 98.14%, with operating and profit margins of -85.40% and -79.50%.
| Gross Margin | 98.14% |
| Operating Margin | -85.40% |
| Pretax Margin | -79.50% |
| Profit Margin | -79.50% |
| EBITDA Margin | -83.36% |
| EBIT Margin | -85.40% |
| FCF Margin | n/a |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.16% |
| Shareholder Yield | -28.16% |
| Earnings Yield | -2.77% |
| FCF Yield | -0.92% |
Analyst Forecast
The average price target for SLNO is $110.90, which is 110.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $110.90 |
| Price Target Difference | 110.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
SLNO has an Altman Z-Score of 16.62 and a Piotroski F-Score of 1.
| Altman Z-Score | 16.62 |
| Piotroski F-Score | 1 |
